357 related articles for article (PubMed ID: 27103598)
21. Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis.
Gallego-Delgado M; González-López E; Muñoz-Beamud F; Buades J; Galán L; Muñoz-Blanco JL; Sánchez-González J; Ibáñez B; Mirelis JG; García-Pavía P
Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):923-930. PubMed ID: 27291669
[TBL] [Abstract][Full Text] [Related]
22. [Problems of diagnostics and treatment of transtiretinum amyloidosis with destruction of the heart in the elderly: Clinical experience.].
Boldueva SA; Petrova VB; Khavinson VK; Samohvalova MV; Petrova AI
Adv Gerontol; 2019; 32(1-2):137-144. PubMed ID: 31228380
[TBL] [Abstract][Full Text] [Related]
23. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy.
Minutoli F; Di Bella G; Mazzeo A; Donato R; Russo M; Scribano E; Baldari S
AJR Am J Roentgenol; 2013 Mar; 200(3):W256-65. PubMed ID: 23436870
[TBL] [Abstract][Full Text] [Related]
24. [Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].
Longhi S; Gagliardi C; Milandri A; Manuzzi L; Rapezzi C
G Ital Cardiol (Rome); 2014 May; 15(5):293-300. PubMed ID: 25002169
[TBL] [Abstract][Full Text] [Related]
25. [Transthyretin cardiac amyloidosis].
Eicher JC; Audia S; Damy T
Rev Med Interne; 2020 Oct; 41(10):673-683. PubMed ID: 32826087
[TBL] [Abstract][Full Text] [Related]
26. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
[TBL] [Abstract][Full Text] [Related]
27. Cardiac amyloidosis with gastrointestinal involvement: a case report.
Tantau A; Avram I; Cozma A; Sampelean D
Med Ultrason; 2015 Mar; 17(1):123-5. PubMed ID: 25745667
[TBL] [Abstract][Full Text] [Related]
28. Cardiac Involvement Secondary to a Familial Form of Transthyretin Amyloidosis Resulting From the Glu54Gln Mutation.
Torres-Courchoud I; Martínez-Gil R; Aibar-Arregui MA; Andrés-Gracia A; Torralba-Cabeza MA
Rev Esp Cardiol (Engl Ed); 2017 Apr; 70(4):297-299. PubMed ID: 27519456
[No Abstract] [Full Text] [Related]
29. Cardiac Amyloidosis in a Child Presenting with Syncope: The First Reported Case and a Diagnostic Dilemma.
Torpoco Rivera DM; Williams CT; Karpawich PP
Pediatr Cardiol; 2022 Mar; 43(3):700-703. PubMed ID: 34783874
[TBL] [Abstract][Full Text] [Related]
30. A representative case of hereditary transthyretin amyloidosis complicated by intramyocardial hemorrhage.
Yagi H; Amiya E; Shintani Y; Nitta D; Numakura S; Hosoya Y; Watanabe M; Fukayama M; Komuro I
Amyloid; 2015 Mar; 22(1):70-2. PubMed ID: 25427692
[No Abstract] [Full Text] [Related]
31. [Cardiac amyloidosis : simplifying the diagnosis of a complex disease].
Dayer N; Monney P; Hugelshofer S
Rev Med Suisse; 2024 May; 20(875):1010-1017. PubMed ID: 38783670
[TBL] [Abstract][Full Text] [Related]
32. [Cardiac amyloidosis: State of art in 2022].
Oghina S; Delbarre MA; Poullot E; Belhadj K; Fanen P; Damy T
Rev Med Interne; 2022 Sep; 43(9):537-544. PubMed ID: 35870985
[TBL] [Abstract][Full Text] [Related]
33. AL amyloid arthropathy and cardiomyopathy presenting with progressive symmetrical fixed flexion deformities and new onset congestive heart failure.
Russo PA; Thomas AC; Selvanayagam JB; Shanahan EM; Ahern M; Smith M
Int J Rheum Dis; 2014 Feb; 17(2):217-8. PubMed ID: 24576279
[No Abstract] [Full Text] [Related]
34. Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis.
Halushka MK; Eng G; Collins AB; Judge DP; Semigran MJ; Stone JR
J Cardiovasc Transl Res; 2015 Jun; 8(4):264-8. PubMed ID: 25925232
[TBL] [Abstract][Full Text] [Related]
35. The premortem recognition of systemic senile amyloidosis with cardiac involvement.
Kyle RA; Spittell PC; Gertz MA; Li CY; Edwards WD; Olson LJ; Thibodeau SN
Am J Med; 1996 Oct; 101(4):395-400. PubMed ID: 8873510
[TBL] [Abstract][Full Text] [Related]
36. Amyloid cardiomyopathy.
Kristen AV
Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
[TBL] [Abstract][Full Text] [Related]
37. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.
Witteles RM; Bokhari S; Damy T; Elliott PM; Falk RH; Fine NM; Gospodinova M; Obici L; Rapezzi C; Garcia-Pavia P
JACC Heart Fail; 2019 Aug; 7(8):709-716. PubMed ID: 31302046
[TBL] [Abstract][Full Text] [Related]
38. Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction.
Castaño A; Bokhari S; Maurer MS
Eur Heart J; 2015 Oct; 36(38):2595-7. PubMed ID: 26224073
[No Abstract] [Full Text] [Related]
39. Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy.
Devesa A; Camblor Blasco A; Pello Lázaro AM; Askari E; Lapeña G; Gómez Talavera S; Taibo Urquía M; Rodríguez Olleros C; Tuñón J; Ibáñez B; Aceña Á
ESC Heart Fail; 2021 Aug; 8(4):2856-2865. PubMed ID: 33963812
[TBL] [Abstract][Full Text] [Related]
40. Where Neurosurgery Meets Heart Failure: A Case Report of a Patient with Amyloid Transthyretin Wild Type in the Ligamentum Flavum and Cardiac Tissue with Bilateral Carpal Tunnel Syndrome.
Dowd RS; Nail TJ; Arkun K; Kryzanski J; Soto O; Fogaren T; Harrington K; Patel A; Comenzo R; Riesenburger RI
World Neurosurg; 2019 Nov; 131():104-107. PubMed ID: 31369882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
